Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IFOSFAMIDE Cause Red cell distribution width increased? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Red cell distribution width increased have been filed in association with IFOSFAMIDE (IFEX). This represents 0.1% of all adverse event reports for IFOSFAMIDE.

13
Reports of Red cell distribution width increased with IFOSFAMIDE
0.1%
of all IFOSFAMIDE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Red cell distribution width increased From IFOSFAMIDE?

Of the 13 reports, 2 (15.4%) required hospitalization, and 1 (7.7%) were considered life-threatening.

Is Red cell distribution width increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does IFOSFAMIDE Cause?

Off label use (2,281) Febrile neutropenia (2,225) Disease progression (1,912) Neutropenia (1,509) Drug ineffective (1,331) Thrombocytopenia (1,227) Anaemia (1,067) Product use in unapproved indication (890) Pyrexia (752) Sepsis (712)

What Other Drugs Cause Red cell distribution width increased?

CLOZAPINE (439) METHOTREXATE (210) ALEMTUZUMAB (202) RITUXIMAB (198) PREDNISONE (178) PALBOCICLIB (171) ADALIMUMAB (144) METHYLPREDNISOLONE (123) ECULIZUMAB (110) TOCILIZUMAB (108)

Which IFOSFAMIDE Alternatives Have Lower Red cell distribution width increased Risk?

IFOSFAMIDE vs IGURATIMOD IFOSFAMIDE vs ILOPERIDONE IFOSFAMIDE vs ILOPROST IFOSFAMIDE vs IMATINIB IFOSFAMIDE vs IMBRUVICA

Related Pages

IFOSFAMIDE Full Profile All Red cell distribution width increased Reports All Drugs Causing Red cell distribution width increased IFOSFAMIDE Demographics